Avalon's laboratory services mso launches innovative laboratory test for tuberculosis

New proprietary testing method makes tuberculosis diagnosis easier and faster new test method expected to generate revenue in 2023 freehold, n.j., aug. 30, 2023 (globe newswire) -- avalon globocare corp. (“avalon” or the “company”) (nasdaq: albt), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced that laboratory services mso, llc (“lsm”) is now offering an in-house laboratory developed test (“ldt”) to detect tuberculosis (“tb”) using a patient's sputum sample.
ALBT Ratings Summary
ALBT Quant Ranking